Literature DB >> 19745069

Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells.

Sanjai Sharma1, Alan Lichtenstein.   

Abstract

Premature termination codon (PTC) mutations are due to insertion or deletion of nucleotides causing a frameshift and premature termination codon in RNA. These transcripts are degraded by the nonsense-mediated decay pathway and have a very short half-life. We used a microarray technique to screen for genes that up-regulate their RNA signal upon nonsense-mediated decay pathway blockade in chronic lymphocytic leukemia (CLL) specimens and identified an E-cadherin transcript with PTC. Sequencing revealed an aberrant E-cadherin transcript lacking exon 11, resulting in a frameshift and PTC. The aberrant E-cadherin transcript was also identified in normal B cells, but occurred at a much lower level compared with CLL cells. In CLL specimens, E-cadherin expression was depressed more than 50% in 62% cases (relative to normal B cells). By real-time polymerase chain reaction analysis, the relative amounts of wild-type transcript inversely correlated with amounts of aberrant transcript (P = .018). Ectopic expression of E-cadherin in CLL specimens containing high amounts of aberrant transcript resulted in down-regulation of the wnt-beta-catenin pathway reporter, a pathway known to be up-regulated in CLL. Our data point to a novel mechanism of E-cadherin gene inactivation, with CLL cells displaying a higher proportion of aberrant nonfunctional transcripts and resulting up-regulation of the wnt-beta-catenin pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745069      PMCID: PMC2774554          DOI: 10.1182/blood-2009-03-206482

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  An mRNA surveillance mechanism that eliminates transcripts lacking termination codons.

Authors:  Pamela A Frischmeyer; Ambro van Hoof; Kathryn O'Donnell; Anthony L Guerrerio; Roy Parker; Harry C Dietz
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

2.  E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.

Authors:  G Merdzhanova; V Edmond; S De Seranno; A Van den Broeck; L Corcos; C Brambilla; E Brambilla; S Gazzeri; B Eymin
Journal:  Cell Death Differ       Date:  2008-09-19       Impact factor: 15.828

3.  Inhibition of beta-catenin-mediated transactivation by cadherin derivatives.

Authors:  E Sadot; I Simcha; M Shtutman; A Ben-Ze'ev; B Geiger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.

Authors:  S Ibrahim; M Keating; K A Do; S O'Brien; Y O Huh; I Jilani; S Lerner; H M Kantarjian; M Albitar
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

5.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene.

Authors:  Rotem Karni; Elisa de Stanchina; Scott W Lowe; Rahul Sinha; David Mu; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

Review 6.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

7.  Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.

Authors:  Desheng Lu; Yandong Zhao; Rommel Tawatao; Howard B Cottam; Malini Sen; Lorenzo M Leoni; Thomas J Kipps; Maripat Corr; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

8.  Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability.

Authors:  Yurij Ionov; Norma Nowak; Manuel Perucho; Sanford Markowitz; John K Cowell
Journal:  Oncogene       Date:  2004-01-22       Impact factor: 9.867

9.  E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.

Authors:  S Orsulic; O Huber; H Aberle; S Arnold; R Kemler
Journal:  J Cell Sci       Date:  1999-04       Impact factor: 5.285

10.  Predominance of null mutations in ataxia-telangiectasia.

Authors:  S Gilad; R Khosravi; D Shkedy; T Uziel; Y Ziv; K Savitsky; G Rotman; S Smith; L Chessa; T J Jorgensen; R Harnik; M Frydman; O Sanal; S Portnoi; Z Goldwicz; N G Jaspers; R A Gatti; G Lenoir; M F Lavin; K Tatsumi; R D Wegner; Y Shiloh; A Bar-Shira
Journal:  Hum Mol Genet       Date:  1996-04       Impact factor: 6.150

View more
  21 in total

1.  Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.

Authors:  Lynda B Bennett; Kristen H Taylor; Gerald L Arthur; Farahnaz B Rahmatpanah; Sam I Hooshmand; Charles W Caldwell
Journal:  Epigenomics       Date:  2010-02-01       Impact factor: 4.778

2.  Mutation screen and RNA analysis disclose the changed splicing of the E-cadherin transcription in gastric cancer.

Authors:  Xiaowei Li; Yafan Gao; Yiyuan Pan; Yan Pan; Lifeng Wang; Nong Xiao; Qiong He; Yimei Fan; Yaping Wang
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

3.  Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.

Authors:  Lauren M Reinke; Yilin Xu; Chonghui Cheng
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

Review 4.  Regulation of cadherin expression in nervous system development.

Authors:  Alicia F Paulson; Maneeshi S Prasad; Amanda Henke Thuringer; Pasquale Manzerra
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

Review 5.  The Kraken Wakes: induced EMT as a driver of tumour aggression and poor outcome.

Authors:  Andrew D Redfern; Lisa J Spalding; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2018-06-08       Impact factor: 5.150

6.  Exon 11 skipping of E-cadherin RNA downregulates its expression in head and neck cancer cells.

Authors:  Sanjai Sharma; Wei Liao; Xiaofeng Zhou; David T W Wong; Alan Lichtenstein
Journal:  Mol Cancer Ther       Date:  2011-07-15       Impact factor: 6.261

7.  E-cadherin plasticity in prostate cancer stem cell invasion.

Authors:  Kyung-Mi Bae; Nicole N Parker; Yao Dai; Johannes Vieweg; Dietmar W Siemann
Journal:  Am J Cancer Res       Date:  2010-10-20       Impact factor: 6.166

8.  Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.

Authors:  Irina V Kovtun; Kimberly J Harris; Aminah Jatoi; Dragan Jevremovic
Journal:  Carcinogenesis       Date:  2011-05-05       Impact factor: 4.944

9.  Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Yoshiki Kubagawa; Matthew K McCollum; Landon Wilson; Tomoko Motohashi; Luigi F Bertoli; James C Barton; Stephen Barnes; Randall S Davis; Hiromi Kubagawa
Journal:  Blood       Date:  2011-09-09       Impact factor: 22.113

10.  Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.

Authors:  Ping Li; David Harris; Zhiming Liu; Jie Liu; Michael Keating; Zeev Estrov
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.